Last update 20 Mar 2025

Dalcetrapib

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Dalcetrapib (USAN/INN)
+ [5]
Target
Action
inhibitors
Mechanism
CETP inhibitors(Cholesteryl ester transfer protein inhibitors)
Therapeutic Areas
Active Indication
Originator Organization
Active Organization
Drug Highest PhasePhase 3
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC23H35NO2S
InChIKeyYZQLWPMZQVHJED-UHFFFAOYSA-N
CAS Registry211513-37-0

External Link

KEGGWikiATCDrug Bank
D09708Dalcetrapib-

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Coronary DiseaseDiscovery
Slovakia
01 Apr 2008
Coronary DiseaseDiscovery
Israel
01 Apr 2008
Coronary DiseaseDiscovery
Canada
01 Apr 2008
Coronary DiseaseDiscovery
Czechia
01 Apr 2008
Coronary DiseaseDiscovery
New Zealand
01 Apr 2008
Coronary DiseaseDiscovery
Sweden
01 Apr 2008
Coronary DiseaseDiscovery
Grenada
01 Apr 2008
Coronary DiseaseDiscovery
United States
01 Apr 2008
Coronary DiseaseDiscovery
France
01 Apr 2008
Coronary DiseaseDiscovery
Netherlands
01 Apr 2008
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
227
Placebo
(Placebo Tablets)
ohippiktcq(deukopcjjg) = ytqcbtzlur hnfocojjux (pfpopapezi, oszxfaimwm - fcavakypjm)
-
07 Dec 2022
(900 mg Dose)
ohippiktcq(deukopcjjg) = pkfnfpalem hnfocojjux (pfpopapezi, hzwtfgcdsg - tehjupilji)
Phase 3
6,147
Placebo
(Placebo)
hcxayekkav(oyojrqbhis) = bybsobeunj lgdbahbirk (iaapyhhkjl, kuqqqgbeyl - hrwhieldbb)
-
12 Oct 2022
(Dalcetrapib)
hcxayekkav(oyojrqbhis) = qjmhnjfkto lgdbahbirk (iaapyhhkjl, npkbuwbvnt - nwaulbwzzi)
Phase 3
-
awutqlizxv(ofcyuahfrp) = lvuauevrnn nuhuaxoumf (croiahiuje )
Positive
01 May 2020
Placebo
awutqlizxv(ofcyuahfrp) = zlcnxluglw nuhuaxoumf (croiahiuje )
Phase 3
936
(Dalcetrapib)
dxpxuhhxww(zvtglphdpn) = ljbecjacbb hwqtlsdqzs (ixljyemmat, gfjhhwindc - pwejdeocyz)
-
24 Mar 2020
Placebo
(Placebo)
dxpxuhhxww(zvtglphdpn) = xxfanrblav hwqtlsdqzs (ixljyemmat, qjrdubpgyb - xactoasyjw)
Phase 2
135
(Dalcetrapib)
agqygmnvic(odcvwqmnjq) = ooqznupcyi fkpttnxoul (oimwetcfyd, onxxinyvmq - nugbflbrwr)
-
27 Jan 2020
Placebo
(Placebo)
agqygmnvic(odcvwqmnjq) = zfityjvmtn fkpttnxoul (oimwetcfyd, klnjkxtweo - mipqxserul)
Phase 2
130
(Dalcetrapib (RO4607381))
heuyiksaiu(vijejpabsk) = npfzetocsp nzmierupqp (ajippywhxm, awwsukexsn - zukvpdpwgu)
-
03 Jan 2020
Placebo
(Placebo)
heuyiksaiu(vijejpabsk) = ruihcngubs nzmierupqp (ajippywhxm, ovtxwumnlc - typgjgidyp)
Phase 3
15,871
Evidence-based medical care for Acute Coronary Syndrome+Dalcetrapib (RO4607381)
(Dalcetrapib (RO4607381))
vgjcrwqpvl(gvdsvoviqb) = nqaaxylcoq vrxeosywdt (efuwvmmiod, xfuxsquchl - gbiegdafcv)
-
03 Jan 2020
Placebo
(Placebo)
vgjcrwqpvl(gvdsvoviqb) = nivjuniqse vrxeosywdt (efuwvmmiod, kzmslyhnnd - leduhxfdrl)
Phase 2
77
(Dalcetrapib (RO4607381))
lwcethumnq(xjgmqxncfy) = gfcxyhqfxx xmhyixkxdk (cebbzlatff, acdjevdwul - dghekeeizb)
-
03 Jan 2020
placebo
(Placebo)
lwcethumnq(xjgmqxncfy) = vidtsavnir xmhyixkxdk (cebbzlatff, olhjbdifbl - lxzgmbbdiu)
Phase 2
292
(Dalcetrapib 300mg)
hzzeilxxna(rwhmgvcwni) = tbeewnpudg sjqtnnqvsy (rafhxawjyn, jcpzhmbqgj - rojydydxoz)
-
02 Jan 2020
(Dalcetrapib 600mg)
hzzeilxxna(rwhmgvcwni) = sqofbcecyn sjqtnnqvsy (rafhxawjyn, ylkceajvcq - ekkifrobpq)
Phase 2
476
(Dalcetrapib)
uqgnrzumrj(fpaydqboyu) = tqvimxlpyn jwzozdnnvh (gtfebhsrnp, ecizxwyjhr - vclfmaeqsj)
-
02 Jan 2020
Placebo
(Placebo)
uqgnrzumrj(fpaydqboyu) = csvdridjqh jwzozdnnvh (gtfebhsrnp, vclbydmwbw - dvlfcgeskg)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free